Guy Witberg News Today

If the LV is likely to improve or normalize with TAVI, there’s no reason not to treat, says Guy Witberg. But for some TAVI might be futile.

TORONTO (CTV Network) -- The risk of developing heart inflammation is two to three times higher with the Moderna COVID-19 vaccine when compared to Pfizer, according to a new Canadian

The risk of developing myocarditis, or heart inflammation, is two to three times higher with the Moderna COVID-19 vaccine when compared to Pfizer, according to a new Canadian study.

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology.

Myocarditis and pericarditis are rare after COVID vaccination, but rates were twofold to threefold higher after receipt of the second dose of the Moderna vaccine than after Pfizer.

New data show a two- to threefold higher risk for myocarditis with the Moderna mRNA vaccine vs the Pfizer vaccine, but a very low overall risk with both vaccines.

While most studies have examined the efficacy of COVID-19 vaccines, not many have explored the differences in myocarditis risk.

The CathWorks FFRangio System to Be Featured in Multiple Live Cases and Clinical Presentations at TCT 2022 

/PRNewswire/ -- CathWorks announced today the schedule of key events for the company during Cardiovascular Research Foundations annual Transcatheter...

CathWorks FFRangio™ System outcomes study to be presented at ACC 2022CathWorks announces the completion of more than 5,000 FFRangio cases globally...